Recent NERV News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:46:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2024 10:21:01 PM
- Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 11/05/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 12:00:18 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/22/2024 11:12:59 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/22/2024 11:09:49 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/22/2024 11:06:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:53 PM
- Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:01:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:25:30 PM
- Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 05/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:04:42 PM
- Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 11:30:30 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • ZEFI • Jan 15, 2025 7:33 AM